We are live on ! Find out more
2C

272 Capital Portfolio holdings

AUM $40M
1-Year Est. Return 150.07%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
+150.07%
3 Year Est. Return
+213.5%
5 Year Est. Return
10 Year Est. Return
AUM
$223M
AUM Growth
+$37.3M
Cap. Flow
+$16.1M
Cap. Flow %
7.23%
Top 10 Hldgs %
51.84%
Holding
88
New
20
Increased
23
Reduced
10
Closed
26

Top Sells

1
ADEA icon
Adeia
ADEA
+$18.8M
2
UIS icon
Unisys
UIS
+$10.7M
3
TWLO icon
Twilio
TWLO
+$3.15M
4
CDZI icon
Cadiz
CDZI
+$2.45M
5
RNG icon
RingCentral
RNG
+$2.3M

Sector Composition

1 Technology 56.28%
2 Communication Services 10.61%
3 Materials 7.55%
4 Industrials 5.73%
5 Healthcare 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SQNS
1
Sequans Communications SA
SQNS
$43.6M
$17.3M 7.73%
208,105
+23,600
+13% +$2.11M
AREN icon
2
Arena Group
AREN
$47.6M
$16.7M 7.47%
1,572,725
+72,748
+5% +$944K
CAMP
3
DELISTED
CalAmp Corp.
CAMP
$15.1M 6.78%
146,916
+28,787
+24% +$2.43M
VPG icon
4
Vishay Precision Group
VPG
$1.38B
$14.8M 6.61%
381,792
+45,000
+13% +$1.64M
SUMO
5
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$9.69M 4.34%
1,196,851
+312,637
+35% +$2.38M
LVOX
6
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$9.29M 4.16%
3,126,276
+596,962
+24% +$1.57M
HBIO icon
7
Harvard Bioscience
HBIO
$28.1M
$8.83M 3.95%
318,730
+147,206
+86% +$3.63M
THR
8
DELISTED
Thermon Group Holdings
THR
$8.55M 3.83%
425,739
-2,824
-0.7% -$52.4K
WKME
9
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$8.39M 3.76%
750,165
+411,907
+122% +$3.62M
RSKD icon
10
Riskified
RSKD
$700M
$7.16M 3.21%
1,549,937
+482,540
+45% +$2.25M
ECVT icon
11
Ecovyst
ECVT
$1.41B
$6.24M 2.79%
703,992
+115,819
+20% +$1.07M
TPB icon
12
Turning Point Brands
TPB
$1.6B
$6.2M 2.78%
286,669
+148,296
+107% +$3.15M
CMP icon
13
Compass Minerals
CMP
$1.24B
$6M 2.69%
146,346
+70,300
+92% +$2.91M
RILY icon
14
BRC Group Holdings
RILY
$275M
$5.57M 2.49%
+162,799
New +$6.82M
CRTO icon
15
Criteo
CRTO
$1.13B
$5.15M 2.31%
197,744
+52,063
+36% +$1.35M
EVBG
16
DELISTED
Everbridge, Inc. Common Stock
EVBG
$5.03M 2.25%
169,927
+40,102
+31% +$1.23M
MX icon
17
Magnachip Semiconductor
MX
$125M
$5.01M 2.24%
533,400
+112,775
+27% +$1.09M
CMRC
18
Commerce.com Inc Series 1
CMRC
$251M
$4.29M 1.92%
+490,311
New +$5.31M
ADEA icon
19
Adeia
ADEA
$2.8B
$4.12M 1.85%
435,114
-1,846,082
-81% -$18.8M
MITK icon
20
Mitek Systems
MITK
$857M
$4.05M 1.81%
417,933
+88,285
+27% +$930K
ACVA icon
21
ACV Auctions
ACVA
$1.3B
$3.87M 1.73%
471,811
-4,079
-0.9% -$34.1K
AVPT icon
22
AvePoint
AVPT
$2.8B
$3.67M 1.64%
893,357
+250,845
+39% +$1.07M
OSPN icon
23
OneSpan
OSPN
$574M
$3.62M 1.62%
323,057
-120,842
-27% -$1.39M
GPRE icon
24
Green Plains
GPRE
$1.35B
$3.39M 1.52%
111,243
+24,422
+28% +$753K
KRMD icon
25
KORU Medical Systems
KRMD
$189M
$3.23M 1.45%
904,025
+130,100
+17% +$359K

Similar funds

272 Capital's Q4 2022 Portfolio in Review

As of Q4 2022, 272 Capital held 88 positions worth $223M, up 20% from $186M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

272 Capital deployed $16.1M of net new capital in Q4 2022, opening 20 new positions and adding to 23 existing holdings. Its largest new stake was BRC Group Holdings: 162,799 shares worth $5.57M.

By sector, the portfolio is most concentrated in Technology at 56% of assets, down from 59% a quarter earlier, followed by Communication Services and Materials.

On the sell side, the largest reduction was Adeia, an estimated $18.8M trimmed.

  • 272 Capital's largest Q4 2022 buy was BRC Group Holdings: 162,799 shares worth $5.57M.
  • 272 Capital added most to Harvard Bioscience in Q4 2022, an estimated $3.63M increase.
  • 272 Capital's biggest Q4 2022 reduction was Adeia, cutting an estimated $18.8M.
  • 272 Capital fully exited Unisys in Q4 2022, selling an estimated $10.7M.
  • 272 Capital's ten largest holdings make up 52% of its $223M portfolio in Q4 2022.
  • 272 Capital opened 20 new positions and closed 26 in Q4 2022.
  • 272 Capital's portfolio value rose 20% quarter-over-quarter to $223M.

Based on 272 Capital's 13F filing for Q4 2022, filed 14 Feb 2023.